{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:24:10Z","timestamp":1777508650687,"version":"3.51.4"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"unspecified","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Physician Quality Improvement Program"},{"DOI":"10.13039\/100012453","name":"Providence Health Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Despite a high prevalence of sexually transmitted and blood-borne infections (STBBIs) among patients with substance use disorders, screening rates in addiction medicine settings are often low. At baseline in our addiction clinic, only 65% of patients were offered screening and only 6% completed screening blood work. This quality improvement project aimed to improve the rate of STBBI screening among new intakes in our clinic by 50%.<\/jats:p>\n               <jats:p>Interventions included the creation of clinic screening guidelines to include annual screening for all patients for HIV, hepatitis B and C, syphilis, gonorrhoea and chlamydia. Additionally, an on-site phlebotomist was hired. These interventions increased screening rates to an average of 33% with the greatest improvement seen after the addition of the phlebotomist. We found that implementing a bundle of interventions improved rates of screening and detection of STBBIs in a low-barrier addiction medicine clinic. Comprehensive infection prevention, screening and linkage-to-treatment protocols are needed to close gaps in care for this vulnerable patient population.<\/jats:p>","DOI":"10.1136\/bmjoq-2024-003088","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:51:22Z","timestamp":1741848682000},"page":"e003088","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Improving screening rates for sexually transmitted and blood-borne infections among patients initiating care in a low-barrier addiction medicine clinic: a quality improvement project"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3267-2712","authenticated-orcid":false,"given":"Genevi\u00e8ve","family":"Kerkerian","sequence":"first","affiliation":[{"name":"Providence Health Care, Vancouver, BC, North America, Canada"},{"name":"Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Fernandez Ruiz","sequence":"additional","affiliation":[{"name":"Department of Physician Quality Improvement, Vancouver Coastal Health Authority and Providence Health Care, Vancouver, North America, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Stanley","sequence":"additional","affiliation":[{"name":"Department of BC Centre for Excellence in HIV\/AIDS, Providence Health Care, Vancouver, North America, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Funaro","sequence":"additional","affiliation":[{"name":"John Ruedy Clinic, Providence Health Care, Vancouver, North America, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma Jean Thorson","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Kirsten","family":"MacIsaac","sequence":"additional","affiliation":[{"name":"Providence Health Care, Vancouver, BC, North America, Canada"},{"name":"Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025083109522480000_14.1.e003088.1","unstructured":"Abuse N . The connection between substance use disorders and hiv. 2020. Available: https:\/\/www.drugabuse.gov\/publications\/research-reports\/common-comorbidities-substance-use-disorders\/part-3-connection-between-substance-use-disorders-hiv"},{"key":"2025083109522480000_14.1.e003088.2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drugalcdep.2016.10.027","article-title":"Substance use and STI acquisition: Secondary analysis from the AWARE study","volume":"169","author":"Feaster","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2025083109522480000_14.1.e003088.3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz133"},{"key":"2025083109522480000_14.1.e003088.4","unstructured":"staff H . STI testing: should i get tested for a sexually transmitted infection. 2022. Available: https:\/\/www.healthlinkbc.ca\/health-topics\/sti-testing-should-i-get-tested-sexually-transmitted-infection"},{"key":"2025083109522480000_14.1.e003088.5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/ADM.0000000000000801","article-title":"Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic","volume":"15","author":"Harvey","year":"2021","journal-title":"J Addict Med"},{"key":"2025083109522480000_14.1.e003088.6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/cid\/ciaa507","article-title":"Missed Opportunities for Human Immunodeficiency Virus (HIV) Testing During Injection Drug Use-Related Healthcare Encounters Among a Cohort of Persons Who Inject Drugs With HIV Diagnosed During an Outbreak-Cincinnati\/Northern Kentucky, 2017-2018","volume":"72","author":"Furukawa","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025083109522480000_14.1.e003088.7","unstructured":"Rio CD . Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic. The National Academics of Sciences, Engineering, medicine; 2020. Available: https:\/\/www.nationalacademies.org\/our-work\/examination-of-the-integration-of-opioid-and-infectious-disease-prevention-efforts-in-select-programs"},{"key":"2025083109522480000_14.1.e003088.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS ONE"},{"key":"2025083109522480000_14.1.e003088.9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6806a4"},{"key":"2025083109522480000_14.1.e003088.10","unstructured":"Public Health Agency of Canada . Canada communicable disease report (ccdr) ccdr 49 2022. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2022-48\/issue-11-12-november-december-2022\/infectious-congenital-syphilis-canada-2021.html [Accessed 14 Dec 2023]."},{"key":"2025083109522480000_14.1.e003088.11","unstructured":"Canada G . Sexually transmitted and blood borne infections (stbbi) prevention guide. 2021. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines\/stbbi-prevention-guide.html"},{"key":"2025083109522480000_14.1.e003088.12","unstructured":"Canada P . Report of hepatitis b and c surveillance in canada: 2019. 2022. Available: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/report-hepatitis-b-c-canada-2019\/report-hepatitis-b-c-canada-2019.pdf"},{"key":"2025083109522480000_14.1.e003088.13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa432"},{"key":"2025083109522480000_14.1.e003088.14","doi-asserted-by":"crossref","unstructured":"Opportunities to improve opioid use disorder and infectious disease services: Integrating responses to a dual epidemic. National Academies of Sciences, Engineering, and Medicine 2020. doi:10.17226\/25626","DOI":"10.17226\/25626"},{"key":"2025083109522480000_14.1.e003088.15","unstructured":"(CCDR), C.C.D.R . Determinants of hiv and hepatitis c among people who inject drugs in canada, 2017-2019. 2020. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2020-46\/issue-5-may-7-2020\/infographic-tracks-survey-canada.html"},{"key":"2025083109522480000_14.1.e003088.16","unstructured":"(WHO), W.H.O . Global HIV, Hepatitis and STIs Programmes: People Who Inject Drugs, 2021. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/populations\/people-who-inject-drugs"},{"key":"2025083109522480000_14.1.e003088.17","unstructured":"AASLD . HCV guidance: recommendations for testing, managing, and treating hepatitis c. key populations: identification and management of hcv in people who inject drugs. 2020."},{"key":"2025083109522480000_14.1.e003088.18","unstructured":"AIDS, a.g.i.a.e.o.h.a. chemsex and hiv. 2020. Available: https:\/\/www.avert.org\/sex-stis\/safer-sex-hiv\/chemsex-and-hiv"},{"key":"2025083109522480000_14.1.e003088.19","doi-asserted-by":"crossref","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: A national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"2025083109522480000_14.1.e003088.20","unstructured":"Public Health Agency of Canada . 2020: estimates of hiv incidence, prevalence and cana\u2019s progress on meeting the 90-90-90 hiv targets, 2020. Available: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/diseases-conditions\/estimates-hiv-incidence-prevalence-canada-meeting-90-90-90-targets-2020\/estimates-hiv-incidence-prevalence-canada-meeting-90-90-90-targets-2020.pdf [Accessed 14 Dec 2024]."},{"key":"2025083109522480000_14.1.e003088.21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa105"},{"key":"2025083109522480000_14.1.e003088.22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025083109522480000_14.1.e003088.23","unstructured":"Canada, P.h.o . Report on sexually transmitted infections in canada, 2018. 2021. Available: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/report-sexually-transmitted-infections-canada-2018.html"},{"key":"2025083109522480000_14.1.e003088.24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.14745\/ccdr.v48i23a03","article-title":"Characterizing female infectious syphilis cases in British Columbia to identify opportunities for optimization of care","volume":"48","author":"Willemsma","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"2025083109522480000_14.1.e003088.25","unstructured":"British columbia centre on substance use. Guideline for the Clinical Management of Opioid Use disorder; 2017. Available: https:\/\/www.bccsu.ca\/wp-content\/uploads\/2017\/06\/BC-OUD-Guidelines_June2017.pdf"},{"key":"2025083109522480000_14.1.e003088.26","unstructured":"Care, P.H . Rapid access addiction rapid access addiction clinic (raac). 2019. Available: https:\/\/www.providencehealthcare.org\/rapid-access-addiction-clinic-raac"},{"key":"2025083109522480000_14.1.e003088.27","unstructured":"Research, P . Research ethics. 2022. Available: https:\/\/www.providenceresearch.ca\/research-ethics"},{"key":"2025083109522480000_14.1.e003088.28","unstructured":"Innovates P . A project ethics community consensus initiative (ARECCI). 2022. Available: https:\/\/albertainnovates.ca\/programs\/arecci"},{"key":"2025083109522480000_14.1.e003088.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2018-000461","article-title":"STI initiative: Improving testing for sexually transmitted infections in women","volume":"7","author":"Chadwick","year":"2018","journal-title":"BMJ Open Qual"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2024-003088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:52:40Z","timestamp":1756659160000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2024-003088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjoq-2024-003088"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2024-003088","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}